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BACKGROUND: The role of the immune system in the pathogenesis of endometriosis remains elusive. It has been
shown that patients have an altered peritoneal environment with increased levels of inﬂammatory cytokines, activated
macrophages and reduced clearance of retrogradely transported endometrial fragments. However, it is not known if
this unique inﬂammatory situation is cause or consequence of endometriosis. This study investigates the impact of a
pre-existing peritoneal inﬂammation on endometriosis establishment in a mouse model. METHODS: Endometriosis
was induced by intraperitoneal injection of enhanced green ﬂuorescent protein (EGFP)-expressing endometrium in
mice. In parallel, a peritonitis model was established via intraperitoneal injection of thioglycolate medium (TM).
Finally, endometriosis was induced in the inﬂamed peritoneal cavity and lesion establishment as well as morphological
and histological characteristics were analysed. RESULTS: Induction of endometriosis in an inﬂamed peritoneal cavity
resulted in fewer lesions and signiﬁcantly lower sum of lesion surface area per mouse in the TM-treated group.
Additionally, a higher amount of non-attached debris could be detected in the peritoneal cavity of TM-treated mice.
CONCLUSIONS: An intraperitoneal inﬂammation decreases endometriosis establishment in this mouse model.
Thus, a pre-existing peritoneal inﬂammation might not be a factor favouring the development of endometriosis.
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Introduction
Endometriosis is a common benign gynaecological disorder
with around 10–22% of all women in reproductive age being
affected (Wheeler, 1989; Moen and Muus, 1991). The
disease is characterized by the presence of endometrial tissue
outside the uterine cavity. Endometriotic lesions are frequently
found in the pelvis minor, e.g. on the ovaries, peritoneum,
pouch of Douglas and rectovaginal septum. Common symp-
toms are severe pelvic pain, dysmenorrhoea and dyspareunia
as well as sub- and infertility (Mahutte and Arici, 2002;
D’Hooghe et al., 2003).
The aetiology of endometriosis is not fully understood yet.
According to the widely accepted theory by Sampson, lesion
development is caused by retrograde menstruation (Sampson,
1927). But it has been shown that despite retrograde men-
struation occurring in around 80% of all menstruating
women (Halme et al., 1984), only 10% of them develop
endometriosis. Thus, it remains to be elucidated which
mechanisms are responsible for adhesion and invasion of
the shed fragments.
Over the last years, the potential role of the immune system
in the pathophysiology of endometriosis has increasingly
gained attention and intense research efforts have been made.
Various studies have been conducted to show that peritoneal
ﬂuid (PF) and peritoneal immune cells of women with endome-
triosis differ from that of healthy women. Examination of the
PF of patients revealed signiﬁcantly increased amounts of cyto-
kines like interleukin (IL)-6, IL-8 and the monocyte chemotac-
tic protein-1, (MCP-1) (Pizzo et al., 2002; Kalu et al., 2007).
MCP-1 is a chemo-attractant that recruits macrophages into
the peritoneal cavity which are able to secret further
pro-inﬂammatory cytokines like Regulated upon Activation,
Normal T cell Expressed and Secreted (RANTES) (Lebovic
et al., 2004), and angiogenic IL-8. Moreover, peritoneal macro-
phages (PMs) are increased in the PF of patients. Additionally,
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Advance Access publication on July 24, 2008these macrophages produce higher levels of IL-1ß, IL-6, IL-8,
IL-10 and tumour necrosis factor-alpha (TNF-a) under basal
and stimulated conditions in vitro compared with PMs of
healthy women (Rana et al., 1996; Montagna et al., 2007).
PMs from women with endometriosis also stimulate eutopic
and ectopic endometrial cell proliferation in vitro (Loh et al.,
1999; Braun et al., 2002) and macrophage-conditioned
medium acts as a growth factor on murine endometrial stromal
cells (Olive et al., 1991). Macrophage secretory products, IL-8
and TNF-a, are known to enhance proliferation and adhesion
of endometrial cells (Arici et al., 1998; Garcia-Velasco and
Arici, 1999; Harada et al., 1999). Proﬁles of other immune
cells are altered as well: natural killer cell cytotoxicity (Vinatier
et al., 1996) and T-cell cytotoxicity is decreased (Harada et al.,
2001) in peritoneal cells from endometriosis patients.
Taken together, these ﬁndings suggest that the immune
system in the peritoneal environment of women with endome-
triosis is altered and seems to be highly activated. So far, it is
not known whether this unique inﬂammatory situation is
caused by endometriosis establishment or results from a pre-
existing inﬂammation.
The present study addresses one aspect of this ‘chicken or
egg’ question, analysing the inﬂuence of a pre-existing perito-
neal inﬂammation on endometriosis establishment in a mouse
model. In this novel approach, endometriosis was induced in
an inﬂamed peritoneal cavity and the effect on lesion establish-
ment was investigated.
Materials and Methods
Mice
Transgenic mice (C57BL/6-Tg(ACTB-EGFP)1Osb/J) ubiquitously
expressing enhanced green ﬂuorescent protein (EGFP) were obtained
from Jackson Laboratories (Maine, USA) and were bred at the Bayer
Schering Pharma AG on-site animal care facility. Mice were fed on
mouse diet and water ad libitum and kept on a light/dark cycle of 12/
12 h under controlled conditions. Female, heterozygous mice, 6–8
monthsold,wereusedasendometriumdonorsand8–12 weeksoldwild-
type C57BL/6 mice (Charles River, Berlin, Germany) as recipient mice.
All procedures involving animals were performed in accordance
with institutional, state and federal guidelines.
Induction of peritonitis
A non-septic non-chronic peritoneal inﬂammation was induced by
injecting thioglycolate medium (TM) as described before (Argyris,
1967). Brieﬂy, peritoneal exudate cells (PECs) were elicited by inject-
ing 1 ml of 3% sterile aged TM Brewer modiﬁed (BD, Sparks, USA)
into the peritoneal cavity. Three days later, mice were sacriﬁced and
PECs were harvested by peritoneal lavage with 5 ml ice-cold, sterile
phosphate-buffered saline (PBS; PAA, Pasching, Austria). After cen-
trifugation, cells were counted using a cell counter (CASY, Schaerfe
System GmbH, Reutlingen, Germany). To exclude potentially con-
taminating erythrocytes, only cells  6 mm in diameter were
counted. Finally, cells were frozen as 1   10
6 cells/100 ml in 10%
dimethyl sulfoxide-containing fetal calf serum (FCS) (Gibco–Invitro-
gen, Karlsruhe, Germany) until further examination.
Fluorescence-activated cell sorting
Cells were thawed on ice, washed twice with PBS, resuspended in
ﬂuorescence-activated cell sorting (FACS)-blocking buffer (1%
bovine serum albumin in PBS containing anti-CD16/CD32 antibody,
Pharmingen/BD Bioscience, San Diego, USA) and incubated for
15 min at 48C. Subsequently, cells were labelled with the following
anti-mouse antibodies: anti-CD11b-FITC, anti-F4/80-PE, anti-GR1-
APC and anti-NK1.1-PE (all BD Bioscience) for 20 min at 48C.
Appropriate isotype antibodies were used as negative control in all
cases. To exclude dead cells, aggregates and debris, cells were gated
using the forward–sideward scatter plot. The data were analysed
using the software CellQuest Pro (BD Bioscience).
In vitro lipopolysaccharide stimulation and cytokine enzyme-linked
immunosorbent assay
Peritoneal cells from six TM-stimulated and six untreated control mice
(5   10
5 cells in 100 ml per well) were cultured in a 96-well-plate
(Corning, USA) using RPMI medium (10% FCS and 1% penicillin/
streptavidin; PAA) for 12 h. Subsequently, plates were washed with
PBS and adhering macrophages were stimulated with 0.1–1000 ng/ml
lipopolysaccharide (LPS) (Sigma–Aldrich, Munich, Germany) for
20 h. Following incubation, supernatants were collected and IL-12
and TNF-a levels were measured by enzyme-linked immunosorbent
assay (ELISA) using maxisorp plates (Nunc, Wiesbaden, Germany)
and ELISA sets (ready-set-go! reagent, eBioscience, San Diego,
USA).
A standard curve was established using serial dilutions of puriﬁed
IL-12 starting at a concentration of 500 pg/ml (1000 pg/ml for
TNF-a). The IL-12 and TNF-a ELISAs were sensitive down to 2
and 8 pg/ml, respectively.
Induction of endometriosis
Induction of endometriosis was performed according to a method
reported by Hirata et al. (2005) with slight modiﬁcations. In contrast
to their work, no estrogen supplementation was given, since it has
been shown that estrogens have an inﬂuence on the immune system
(Straub, 2007). To avoid any impact of estrogens, intact donor mice
were used and recipient mice were not supplemented with estrogen.
Brieﬂy, EGFP-transgenic mice in estrus state were anaesthetized
with CO2 and killed by cervical dislocation. The uterus horns were
removed and stored in 378C warm Dulbecco’s modiﬁed eagle
medium (DMEM w/o phenol red, Gibco–Invitrogen). Endometrium
was peeled off with tweezers and chopped into 400   400 mm wide
pieces using a tissue chopper (McIwain tissue chopper, Agar Scienti-
ﬁc, Essex, UK). The endometrium fragments of two uteri were pooled
and every recipient mouse received 40 mg tissue in 400 ml warm
DMEM. The suspended tissue was injected into the peritoneal
cavity through the abdominal wall with a 20-gauge needle on the
midline just below the umbilicus. During this procedure, recipient
mice were anaesthetized with dimethyl ether. Ten days after the injec-
tion of endometrium fragments, the mice were sacriﬁced.
Fluorescence imaging of EGFP-expressing tissues
Ten days after the injection of the endometrial fragments, mice were
euthanized with an overdose of dimethyl ether. Autopsy was per-
formed by a longitudinal midline incision. A stereo-microscope
(Stemi SV6, Carl Zeiss AG, Go ¨ttingen, Germany) with a ﬂuorescence
device and a camera (AxioCam HRm, Zeiss) was used to illuminate
the peritoneal cavity. EGFP-expressing lesions and non-attached
tissue fragments were removed and snap-frozen in optimal cutting
temperature compound Tissue-Tek (Sakura Finetek, Zoeterwoude,
The Netherlands) in liquid nitrogen or ﬁxed with 4% paraformalde-
hyde (PFA) in PBS for 24 h.
Induction of endometriosis in inﬂamed peritoneal cavity
First, peritonitis was induced as described above in wild-type
C57BL/6 mice (n ¼ 20). The control animals (n ¼ 20) were not
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injected each with 40 mg of EGFP-expressing endometrium fragments
under anaesthesia as described above. Ten days after injection, mice
were sacriﬁced and the peritoneal cavity was examined under ﬂuor-
escent light. Lesions were excised, photographed and measured
using the software Axiovision. Non-attached debris was taken out
and counted. Finally, lesions and debris were snap frozen or ﬁxed in
PFA for further analysis.
Histological and immunohistochemical examinations
Frozen tissues were cut at10 mm on a cryostat.PFA-ﬁxedlesions were
embedded in parafﬁn and cut at 5 mm thickness. For gross
examination, sections were stained with haematoxylin–eosin.
Weigert-Elastica-van Gieson (W-E-vG) staining was performed
using resorcin–fuchsin red (Merck, Darmstadt, Germany), iron
haematoxylin (Merck) and picrin acid (Fluka Biochemika, Buchs,
Switzerland) combined with thiazin red (Chroma, Muenster,
Germany) leading to black–brown coloured nuclei, black coloured
elastic ﬁbres, red coloured collagen connective tissue and yellow
coloured muscle tissue.
Immunohistochemical examinations were carried out using either
the DAKO EnVision protocol for rabbit antibodies (Carpinteria,
USA), a Mouse-to-Mouse detection kit protocol for mouse mono-
clonal antibodies (Chemicon-Millipore, Temecula, USA) or the
ABC streptavidin–biotin method. Binding of primary antibody was
carried out overnight at 48C using the following antibodies: mono-
clonal rat anti-mouse Ki67 (DAKO), monoclonal mouse anti-mouse
cytokeratin (CK), multi Ab-1 (clone C11, Dianova, Hamburg,
Germany), polyclonal rabbit anti-mouse estrogen receptor alpha,
(clone MC-20, Santa Cruz Biotechnology, Santa Cruz, USA), polyclo-
nal rabbit anti-mouse smooth muscle actin (Spring Bioscience,
Fremont, USA). Negative controls were only incubated with antibody
diluent (DAKO). Counterstaining was performed with haematoxylin
(Merck). The results were analysed and documented with the micro-
scope AxioPlan 2 and an AxioCam camera (Zeiss) using the software
AxioVision Rel. 4.5.
Statistical analysis
The peritoneal cell counts of all animals were averaged and are pre-
sented as mean+standard deviation (SD). Statistical analysis of
cell counts was performed with Mann–Whitney rank sum test by
using SigmaStat 3.0 (Systat, San Jose, USA).
The lesions were measured and the cross-sectional areas (CSAs) for
every lesion were calculated according to the formula for an ovoid:
diameter 1   diameter 2   p/4 (Becker et al., 2005; Efstathiou
et al., 2005). All CSAs were taken for further analysis and only
animals with lesions were included. Log-transformed values were
used for the statistical comparisons of CSA between control and
TM-treated animals. A general mixed linear model was ﬁtted, using
the treatment group as ﬁxed effects and animal as random experimen-
tal unit. To model the covariance structure between the measurements
of each animal, a compound symmetry structure was assumed.
Different covariance structures were used between the treatment
groups. The Kenward–Rogers approach was applied for the calcu-
lation of the denominator degrees of freedom for the F-tests in a two-
sided test.
Additionally, the sum of the CSA of the lesions per mouse was used
as a measure for the overall burden of the animal. In this analysis, all
20 animals in both groups were considered. To compare the overall
burden, an exact two-sided Wilcoxon rank-sum test was used on the
sum of the CSAs per animal. Animals without lesions were included
with value zero.
The analyses were performed using PROC MIXED in SAS
w,
Version 9.1.3 (Heidelberg, Germany). Probability P , 0.05 was
considered as statistically signiﬁcant.
Results
Evaluation of thioglycolate-induced acute peritoneal
inﬂammation
A well-known method to induce a non-chronic inﬂammatory
response in the murine peritoneal cavity is the intraperitoneal
injection of TM (Li et al., 1997). To characterize the elicited
inﬂammatory response, PECs were harvested by peritoneal
lavage 3–5 days after TM-injection. In response to TM treat-
ment, an increase in peritoneal cell counts could be detected.
Highest cell numbers were found on Day 3 showing a 9-fold
increase within the PF of TM-treated mice compared with
PBS-treated controls (11.6+5.3   10
6 versus 1.3+0.5  
10
6; P , 0.01; Fig. 1a). Cell counts gradually declined there-
after on Day 4 and 5 (data not shown) indicating an acute, non-
chronic inﬂammation.
FACS analysis of PEC revealed an increase in different
innate immune cells in the TM-treated mice compared with
controls. Numbers of macrophages (F4/80- and CD11b-
positive) were signiﬁcantly elevated in the treatment group
(8.3+3.1   10
6 versus 0.8+0.3   10
6; P , 0.001, Fig. 1b)
representing 70% of the total cell number, thus demonstrat-
ing that macrophages are the predominant cell type in the
inﬂamed peritoneal cavity. In addition, populations of granulo-
cytes (GR1-positive) and natural killer cells (NK1.1-positive)
were signiﬁcantly increased (Fig. 1b). PM of TM-stimulated
and control mice were isolated from the PF and cultured in
vitro to examine their cytokine secretion. Cytokine levels of
TNF-a and IL-12 (data not shown) were increased in the
TM-group compared with controls after 20 h LPS stimulation
(Fig. 1c) although this was not statistically signiﬁcant. In the
PF, no inﬂammatory cytokines could be detected (data not
shown).
Taken together, these ﬁndings demonstrate that i.p. injection
of TM into mice leads to an acute non-septic peritonitis with
increased levels of innate immune cells. Furthermore, the cyto-
kine levels in vitro suggest a higher activity of macrophages
after TM treatment, which thus resemble macrophages from
endometriosis patients.
Induction of endometriosis
EGFP-expressing endometrium fragments were injected into
the peritoneal cavity of C57BL/6 mice. On average, 95% of
the animals developed around 2–3 endometriosis-like
lesions. Macroscopically, lesions consisted of white–light
yellow ellipsoid nodules that were 0.5–4 mm in diameter.
They were formed on the omentum, peritoneum, pancreas
and its surrounding fatty tissue. Lesions could also be detected
behind the bifurcation of the uterus as well as embedded in the
fatty tissue around the uterine horns (Fig. 2a). As exempliﬁed,
all lesions emitted green light under ﬂuorescence light
(488 nm, Fig. 2b).
The frozen section in Fig. 2a–c illustrates the presence of
EGFP-expressing cells under ﬂuorescent light. Some parts of
Nowak et al.
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escence, whereas others display only weak or no ﬂuorescence.
Typical histological characteristics of endometriotic lesions
could be demonstrated by immunohistochemistry. Staining
against speciﬁc CKs (CK8, CK18) conﬁrms the presence of
glandular epithelium (Fig. 3a). Proliferation marker Ki67 stain-
ing reveals cell proliferation within the epithelium and sur-
rounding stromal cells. Moreover, proliferating cells can be
seen in the content of the cystic lumen (Fig. 3b). Estrogen
receptor alpha positive cells, displayed by brown nuclei, can
be detected in the lesion epithelium as well as in stromal struc-
tures (Fig. 3c). Finally, the W-E-vG staining demonstrates the
presence of collagen connective tissue which appears red after
the trichrom staining (Fig. 3d).
In conclusion, the injection of EGFP-expressing endome-
trium leads to development of endometriotic lesions, display-
ing typical characteristics of endometriosis as seen in
histological analysis. Thus, this model is a valuable tool to
examine endometriosis in vivo.
Figure 3: Histological and immunohistochemical examination of
EGFP-expressing endometriotic lesions.
(a) Anti-CK staining shows glandular epithelial cells. (b) Proliferating
cells positive for Ki67 in cyst epithelium, stroma and in cyst content
display red stained nuclei. (c) Estrogen receptor alpha positive cells
in epithelium and stroma are indicated by brown stained nuclei. (d)
W-E-vG staining of an endometriotic lesion reveals collagen con-
nective tissue in red and nuclei in black. Scale bar: a, c, d ¼ 50 mm,
b ¼ 100 mm. Original magniﬁcation: a, c, d ¼  200, b ¼  100.
Figure 1: Differences in peritoneal cell number and proﬁles after
TM-stimulation compared with control.
(a) Total cell amount after peritoneal lavage in control mice (n ¼ 12;
1.3+0.5   10
6) and TM-treated mice (n ¼ 12; 11.6+5.2   10
6)3
days after TM-injection (**P , 0.01). (b) After analysing the PECs
by FACS, higher total amounts of innate immune cells like neutrophils
(CD11b; 7.9+3.3   10
6 versus 0.5+0.4   10
6), macrophages
(CD11b and F4/80 positive; 8.3+3.1   10
6 versus 0.8+0.3  
10
6), granulocytes (GR1; 3.0+2.3   10
6 versus 0.6+0.3   10
6)
and natural killer cells (NK1.1; 3.6+1.9   10
6 versus 0.2+0.08  
10
6) were detected in TM-treated mice (***P , 0.001). (c)A
concentration-dependent increase of TNF-a was detected after LPS
stimulation in the supernatant of pooled PM from TM-stimulated
mice (n ¼ 6) and resident macrophages from control mice (n ¼ 6).
All results are expressed as mean+SD. Statistical analysis was per-
formed using Mann–Whitney rank sum test.
Figure 2: Macroscopic and histological appearance of an enhanced
green ﬂuorescent protein expressing lesion embedded in fat tissue
10 days after injection of endometrium fragments.
(a) Lesion under impinging light shows the embedding in blood sup-
plied fat tissue. Supporting blood vessels are indicated by arrows. (b)
Same lesion examined under ﬂuorescent light. A supporting blood
vessel is indicated by the arrow. (c–e) Picture of a frozen lesion
section taken with 800 ms exposure time showing (c)
EGFP-expressing cells under ﬂuorescent light, (d) all nuclei
(DAPI-staining) and (e) the merged image. Scale bar a–b ¼ 1 mm,
c–e¼ 100 mm. Original magniﬁcation c–e:  100.
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Following induction of peritonitis, endometrial tissue frag-
ments were injected into the peritoneal cavity of TM-treated
mice. Lesions formed under these conditions were examined
after autopsy and compared with lesions from endometriosis
control mice. On gross examination, fewer mice with lesions
were found in the TM-treated group (Table I). Five of twenty
mice (25%) developed no endometriosis compared with one
of 20 (5%) in the control group. Furthermore, peritoneal cav-
ities of TM-treated mice contained more non-attached debris
than those of control animals. Ninety percent of TM-treated
mice had non-attached tissue fragments in their peritoneal cav-
ities compared with 40% in the control group (Table I), indicat-
ing a defect in adhesion processes, whether among the
endometrial fragments and/or on the peritoneal surfaces.
This ﬁnding is supported by a reduced average lesion number
of 1.65 per mouse (75% take rate) in the TM-treated group
and 2.04 in the control group (95% take rate). Moreover,
lesions from TM-treated mice were smaller compared with
controls (median CSA: 0.60+1.86 versus 1.60+5.99 mm
2;
Fig. 4a). The CSAs in the TM-treated group tended to be
48% of those in the control group, with a 95% conﬁdence
limit of [20.3%, 114%] (P ¼ 0.0943). In this analysis, only
mice with lesions were taken into account.
Another examined parameter was the sum of the CSA of the
lesions per mouse, used as a measure for the overall disease
burden of the animal. Statistical analysis revealed that the
TM-treated mice had a signiﬁcantly reduced overall disease
burden. The box plot (Fig. 4b) of the sum of the CSA per
mouse shows the statistically signiﬁcant difference between
the two groups. The median overall burden in the TM-treated
group was 0.92 mm
2, which was signiﬁcantly lower than the
overall burden of 8.8 mm
2 in the control group (P ¼ 0.0013;
n ¼ 20 per group).
The histological examination of lesions was carried out by
morphological identiﬁcation following haematoxylin–eosin
staining and immunohistochemistry. In both groups, the
lesions displayed endometriotic characteristics like glandular
epithelium and stromal cells. They had either a compact
Table I. Comparison of different parameters analysed for lesion
establishment and appearance in control mice and TM-stimulated mice
(n ¼ 20 per group).
Parameter Control TM-group P-value
Mice with no lesions 1 (5%) 5 (25%)
Mice with debris 8 (40%) 18 (90%)
Mean lesion number per mouse 2.40+1.4 1.65+1.4
Lesion number range 0–6 0–4
Mean of CSA/mouse (mm
2) 4.86+4.52 1.41+1.63
Median of CSA (mm
2) 1.60+5.99 0.60+1.86
Geometric mean of CSA (mm
2) 1.33+6.28 0.60+3.48
Sum CSA of all lesions (mm
2) 217.43 44.18
Median of sum CSA (mm
2) 8.8+9.93 0.92+3.26 0.0013
Statistical analysis: F test (CSA), Wilcoxon rank-sum test (Sum CSA).
CSAs, cross-sectional areas.
Figure 4: CSA and sum of the CSAs of endometriotic lesions in con-
trols compared with TM-stimulated mice shown in box plots.
(a) Ten days after injection of EGFP-expressing endometrium
fragments in the inﬂamed peritoneal cavity, the CSA of lesions was
determined in controls and TM-treated animals with lesions. Compari-
son displayed a tendency towards smaller CSA (P ¼ 0.0943). (b) The
sum of CSAs per mouse was compared between all controls and all
TM-treated mice showing a signiﬁcantly lower disease burden in
treated animals (**P ¼ 0.0013). The solid line indicates the median,
the dashed line the mean. Statistical analysis was performed using a
two-tailed F-test for CSA comparison and a two-tailed Wilcoxon
rank-sum test for analysis of sum CSA.
Figure 5: Histological examination of lesions.
(a) Haematoxylin–eosin stained lesion from a TM-treated mouse with
compact content, showing supporting vessels (indicated by arrows)
embeddedin fat(f),several sites of mineralization (m)and eosinophile
patches (e). (b) Lesion from a control mouse with cystic lumen (L)
surrounded by stromal cells and supporting vessels. (c) Immunohisto-
chemical smooth muscle actin staining reveals small vessels in the
supporting fat tissue and a few pericytes in the lesions (Le), indicated
by the arrows. No further actin staining can be detected. Scale bars:
100 mm. Original magniﬁcation: a ¼  50, b–c ¼  100.
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porting blood vessels embedded in fat can be seen on Fig. 5a.
Furthermore, haematoxylin–eosin staining revealed several
eosinophile patches within the lesion, which could be identiﬁed
as collagen connective tissue by W-E-vG staining (data not
shown). Moreover, mineralization of tissue could be seen in
TM-treated mice and controls in both lesion types (cystic and
compact) indicating necrosis.
Immunohistochemical examination with alpha-smooth
muscle actin antibodies displayed only a low number of posi-
tive cells in the lesions from both groups, but strong signals
in surrounding vessels (Fig. 5c), indicating that there are no
muscle ﬁbres (e.g. myometrium) and only a few pericytes in
the lesions. Additionally, this staining illustrated the rich
blood supply of the lesions.
Another difference between TM-treated mice and controls
besides the lesion number was the incidence of non-attached
debris. Ninety percent of TM-treated mice and 40% of
control mice displayed intraperitoneally non-attached
fragments. Fig. 6a shows the high amount of loose fragments
taken out of a TM-treated mouse, on average 12–15 pieces.
Control mice had only around one to three pieces per mouse.
Histological examination of debris sections revealed a
heterogenic, diffuse structure. No glandular epithelium could
be detected and a cystic lumen could only be seen in one
single piece of a control mouse (Fig. 6c). Eosinophil patches
occurred in different places which could be further character-
ized as collagen connective tissue as shown by W-E-vG stain-
ing. Additionally, in the debris sections no CD31 positive cells
could be detected (data not shown) and several necrotic areas
could be seen.
Taken together, the induction of endometriosis in an
inﬂamed peritoneal cavity resulted in fewer lesions per
mouse and a smaller lesion size as well as lower disease
burden compared with non-treated controls. Furthermore,
more mice with debris in the peritoneal cavity were detected
in the TM group with a higher amount of debris per mouse.
Discussion
In the pathogenesis of endometriosis, the role of the immune
system still remains enigmatic. It has been shown that endome-
triosis patients have an altered peritoneal environment and their
peritoneal immune cells differ from cells of healthy subjects.
However, there is an impaired clearance of regurgitated endo-
metrial tissue pieces in the peritoneal cavity. The present study
focused on the inﬂuence of inﬂammation on endometriosis
establishment by combining a peritonitis mouse model with
an endometriosis model.
Peritoneal inﬂammation was induced by intraperitoneal
injection of TM. This method has been routinely used for
several decades (Argyris, 1967). Induction of peritonitis can
also be achieved by injection of other agents, such as casein,
bacillus Calmette-Gue ´rin vaccine or methylated bovine
serum albumin (mBSA) (Cook et al., 2003; Hrabak et al.,
2006), each leading to different effects on peritoneal cells.
Comparison between mBSA and TM revealed that TM injec-
tion recruited more immune cells into the peritoneal cavity
than mBSA treatment (Cook et al., 2003). In addition, macro-
phages were larger, more vacuolated and displayed different
surface marker distribution compared with resident and
mBSA-elicited macrophages (Cook et al., 2003). Furthermore,
the TM-excited macrophages resemble activated macrophages
in many respects (Den Otter et al., 1982). In addition, isolated
TM-elicited macrophages revealed increased TNF-a and IL-12
secretion, a characteristic also seen in endometriosis patients
(Rana et al., 1996; Wu et al., 1999). Thus, the injection of
TM was used as a model for an acute pre-inﬂamed peritoneal
cavity with features resembling the detected inﬂammatory situ-
ation in patients.
Examining endometriosis evokes the need of a model
system. The only animals that are known to develop endome-
triosis spontaneously are primates, two baboon species
(Papio anubis and Papio cynocephalus) and the rhesus
monkey, Macaca mulatta (MacKenzie and Casey, 1975;
D’Hooghe et al., 1991). The long period until endometriosis
occurs and the infrequent rate make this model hardly
Figure 6: Non-attached debris of a TM-treated mouse removed after
autopsy.
(a) Debris under ﬂuorescent light in a TM-treated mouse. (b) Haema-
toxylin–eosin staining of a parafﬁn-embedded debris section. Eosino-
phil patches are indicated by arrows. Mineralized tissue (m)
demonstrates ongoing necrosis. (c) W-E-vG staining of a debris
section. Collagen connective tissue stains red, muscle yellow and
nuclei black. Scale bar: a ¼ 2 mm, b ¼ 200 mm, c ¼ 100 mm. Orig-
inal magniﬁcation: b ¼  50, c ¼  100.
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models can be used. Somigliana et al. (1999) showed very suc-
cessfully the establishment of endometriosis-like lesions in the
mouse after endometrium injection. In the present study, a
slightly modiﬁed method was used by injecting
EGFP-expressing endometrium into intact wild-type mice.
Endometrial fragments expressing EGFP were used to facili-
tate the discovery of small, hidden lesions which are not detect-
able under impinging light. Compared with a transplantation
model, which involves sutured uterus biopsies on mouse gut
mesenterium (Cummings and Metcalf, 1995), the tissue frag-
ments in this model adhere spontaneously after injection onto
speciﬁc locations like the omentum and peritoneum. These
observations correspond to previous results reported by
Hirata et al. (2005). Interestingly, approaches from Vernon
and Wilson to inject endometrial scrapes into the peritoneal
cavity of a rat did not show lesion establishment. According
to the authors, this might have been due to a very short treat-
ment period of 14 days (Vernon and Wilson, 1985).
Another frequent site of adherence is the fatty tissue around
the uterus and pancreas, presumably due to estrogen production
in fat tissue (Brodie, 1979). The predisposition of lesions for
fatty tissues is a phenomenon also described by other authors
investigating endometriosis establishment in murine models
(Somigliana et al., 1999; Hirata et al., 2005). Adipose tissues
produce estrogens and thus might support the lesion’s
growth. However, other pro-angiogenic factors derived from
these tissues might have an impact as well. The cytokine
leptin, for example, is secreted by adipocytes and has strong
angiogenic features (Sierra-Honigmann et al., 1998). Further-
more, it has been shown that its absence or ablation disrupts
the establishment of endometriosis-like lesions in a mouse
models (Styer et al., 2008). The role of fatty tissue as favourite
attachment site is an interesting ﬁnding and seems to be import-
ant beyond estrogen production in this model. In patients, high
concentrations of leptin have been found in the PF (Matarese
et al., 2000), but to our knowledge, fatty tissues are not
favoured attachment sites for endometriotic lesions in humans.
Our observations of lesion surface area in the endometriosis
model revealed that despite the injected tissue fragment size of
400   400 mm, lesions with a size up to 4 mm in diameter
could be detected. This may be due to an adherence of pieces
with each other and the subsequent growth of the conglomer-
ate. The immunohistochemical stainings for Ki67 in Fig. 3b
show that epithelial cells as well as stromal cells of lesions con-
tinue to proliferate, thus conﬁrming lesion growth. Further
immunohistochemical evaluations demonstrated that glandular
epithelium as well as estrogen receptor alpha are present in this
EGFP-endometrium derived lesions, which has not been shown
before. Examination of frozen lesion sections under ﬂuorescent
light revealed heterogenic distribution of EGFP, with some
stroma and epithelial cells not emitting green light (exposure
time: 800 ms). Interestingly, analysis of EGFP uterus sections
also displayed varying EGFP ﬂuorescence in stroma and epi-
thelial cells (data not shown). Indeed, using an extended
exposure time, these cells in the endometrium as well as in
the lesions show a green ﬂuorescence. Hence, we conclude
that the cells in Fig. 2 not displaying green ﬂuorescence still
derive from EGFP-endometrium. Non-EGFP expressing host
cells are mainly found at the border of lesions in the attachment
zone, like it also has been shown by Hirata et al. (2005).
The very low detection of alpha-smooth muscle actin in
lesions after immunohistochemical staining suggests that
there are only a few pericytes present in the tissue sections.
Pericytes usually surround endothelial cells and build together
with the basal membrane the mature microvessel. In contrast,
immature microvessels consist only of endothelial cells. Endo-
metriosis is strongly associated with neovascularization
(Groothuis et al., 2005; Becker and D’amato, 2007; Laschke
and Menger, 2007) and immature vessel formation (Hull
et al., 2003). Thus, the lesions developed after the injection
of EGFP expressing endometrium somehow display the
characteristic neovascular situation detected in human endo-
metriotic lesions.
To investigate the impact of inﬂammation on endometriosis
establishment, the peritonitis model was combined with the
endometriosis model. The induction of a broad acute inﬂam-
mation followed by endometriosis induction has not been pub-
lished before. Peritonitis was evoked by single treatment with
TM and, 3 days later, endometriosis was induced by injection
of EGFP-expressing endometrial fragments. When analysing
the amount and size of lesions established in the peritoneal
cavity a signiﬁcantly lower overall disease burden expressed
as sum of the CSA per mouse was detected in the TM-treated
mice.
Additionally, although not statistically signiﬁcant, the per-
itoneal cavity of mice treated with TM contained more non-
attached debris. This might be due to impaired adherence of
the tissue fragments with each other and with peritoneal sur-
faces, leading to the high amount of debris detected in
TM-injected mice. At the time of endometrium injection, the
peritoneal cavity of TM-treated mice contained around
10-fold more macrophages than that of control mice. Macro-
phages can execute diverse functional activities including pha-
gocytosis and oxidative burst, matrix dissolution and tissue
remodelling (Janeway et al., 2005). Additionally, Lin et al.
could show that macrophages and neutrophils inﬁltrate into
ectopic endometrial tissue and the peritoneal cavity. Their
local secretion of cytokines and chemokines possibly inﬂu-
ences the development of lesions, too (Lin et al., 2006).
Hence, we hypothesize that elevated numbers of macrophages
lead to increased phagocytosis, cell destruction through rad-
icals released at respiratory burst and, ﬁnally, to a pronounced
tissue degradation, impairing the adherence abilities of the
endometrium fragments.
Moreover, a higher clearance of tissue fragments due to an
increased phagocytosis rate could be an explanation for fewer
lesions in the TM-treated mice. Endometrium of
EGFP-expressing mice was peeled off the myometrium,
chopped and suspended in medium. Consequently, tissue
integrity was broken and damaged cells including their
former content were injected into the peritoneal cavity. This
process attracts macrophages and phagocytosis starts. Thus, a
10-fold increase of cells capable of phagocytosis detected
after TM injection might lead to a faster clearance of the
tissuethanitwouldoccurwithanunstimulatedimmunesystem.
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decreases the establishment of endometriosis-like lesions in
this mouse model. To our knowledge, this is the ﬁrst study
investigating the impact of an inﬂamed peritoneal environment
on the establishment of endometriotic lesion in the EGFP
mouse model. Our results correspond to another study with a
pro-inﬂammatory compound published by Somigliana et al.
(1999). They demonstrated that treatment with the recombinant
cytokine IL-12 (2 days prior endometriosis induction until 2
days after) effectively reduced ectopic implantation of endo-
metrial fragments in a mouse model. IL-12 inﬂuenced the
immune system speciﬁcally by favouring the generation of
T-helper 1 response. Furthermore, the authors proposed
’IL-12 may enhance the growth and augment the cytolytic
activity of both NK/LAK (lymphokine-activated killer) and
T cells’ and thus lead to reduced endometriosis establishment.
Hence, in contrast to TM, which elicits a broad inﬂammation,
IL-12 activates a particular pathway of immune response.
Interestingly, Efstathiou et al. have found that a treatment
with non-steroidal anti-inﬂammatory drugs (NSAIDs) also
reduces disease burden in an endometriosis mouse model.
According to the authors, the NSAIDs used in their exper-
iments display characteristics beyond anti-inﬂammatory fea-
tures. They suggested that celecoxib, for example, might be
associated with induction of apoptosis in the endometriotic
explants. Additionally, another cause for lesion reduction
could be the inhibiting effects of NSAIDs on angiogenesis
(Efstathiou et al., 2005). A potential explanation for this con-
troversy might be, that TM-induced inﬂammation, IL-12 and
NSAIDs all act through different mechanisms and pathways
leading ﬁnally to the same outcome, the reduced endometriosis
establishment. Taken together, all these data suggest that not
only one pathway but several factors are involved in the devel-
opment of the disease and underline the importance of the
immune system in this condition.
Regarding the altered immune system in the peritoneal
cavity of endometriosis patients, the stimulus responsible for
this inﬂammatory situation has not been demonstrated yet. A
possible reason could be that the regurgitating menstrual
tissue fragments evoke this inﬂammatory environment.
Approaches have been made to investigate this hypothesis.
Haney et al. examined if menstrual debris might be the stimu-
lus responsible for PF inﬂammation and concluded that these
tissue fragments are probably not a major factor. After examin-
ing the correlation of endometriosis extent with PF volume and
cells, they did not ﬁnd a signiﬁcant relationship (Haney et al.,
1991). Alternatively, an already existing peritoneal inﬂam-
mation before endometriosis establishment might be an expla-
nation for the detected inﬂammatory events in the peritoneal
cavity of patients. However, in our mouse model, we could
show that an acute peritonitis does not increase the establish-
ment of lesions.
As for the human, the induced peritoneal inﬂammation in
this study represents only certain aspects of the inﬂammatory
events observed in endometriosis. A primary defect like abnor-
mal macrophage function in endometriosis patients is an
obvious possibility as a leading factor underlying lesion estab-
lishment. Additionally, a lower phagocyting capacity caused
by lesion derived proteins is postulated for PM from endome-
triosis patients (Sharpe-Timms et al., 2002).
In conclusion, the initiation of an inﬂammatory response in
the peritoneal cavity followed by endometriosis induction
seems to be a valuable technique to investigate the role of
the immune system in this disease. The study could show
that pre-existing inﬂammation does not increase disease
burden in a mouse model and thus might not be the main
factor favouring the development of endometriosis. In human
patients other factors like primary macrophage defects rather
than inﬂammation may be responsible for endometriosis estab-
lishment. Thus, further experiments should be conducted to
examine the impact of immunologic alterations on endometrio-
sis establishment to gain deeper knowledge of involvement of
the immune system in this disease.
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